BamSEC and AlphaSense Join Forces
Learn More

Tenaya Therapeutics Inc. – Material Contracts

NASDAQ: TNYA    
Share price (6/2/26): $0.79    
Market cap (6/2/26): $171 million

Material Contracts Filter

EX-10.1
from 8-K 21 pages Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.2
from 10-Q 51 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is (1) Not Material and (2) the Type That the Registrant Treats as Private or Confidential. [***] Indicates That Information Has Been Redacted. Collaboration Agreement by and Between Alnylam Pharmaceuticals, Inc. and Tenaya Therapeutics, Inc. Collaboration Agreement
12/34/56
EX-10.11
from 10-K 6 pages Tenaya Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.1
from 8-K 48 pages Tenaya Therapeutics, Inc. 2024 Inducement Equity Incentive Plan (As Amended and Restated) 1. Purposes of the Plan. the Purpose of This Plan Is to Attract and Retain the Best Available Personnel for Positions of Substantial Responsibility by Providing an Inducement Material to Individuals Entering Into Employment With the Company or Any Parent or Subsidiary of the Company
12/34/56
EX-10.10
from 10-K 4 pages I Am Pleased to Offer You a Position With Tenaya Therapeutics, Inc. (The "Company"), as Its Vice President, Finance Reporting to Faraz Ali, M.B.A., Chief Executive Officer. if You Accept Our Offer, Your First Day of Employment Will Be as Soon as Practicable, but No Later Than January 13, 2020 (The Day You Actually Commence Employment Hereunder, the "Employment Commencement Date"). 1
12/34/56
EX-10.1
from 8-K 49 pages The Plan Permits the Grant of Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Awards. Each Award Under the Plan Is Intended to Qualify as an Employment Inducement Award Under NASDAQ Listing Rule 5635(c)(4), the Official Regulations and Other Official Interpretive Material and Guidance Issued Under Such Rule (Together, the “Inducement Listing Rule”). 2. Definitions. as Used Herein, the Following Definitions Will Apply: 2.1 “Administrator” Means the Board or Any of Its Committees as Will Be Administering the Plan, in Accordance With Section 4 of the Plan. 2.2
12/34/56
EX-10.1
from 10-Q 6 pages First Amendment to Lease
12/34/56
EX-10.10
from 10-K 6 pages Tenaya Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 6 pages Tenaya Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.1
from 8-K 24 pages Tenaya Therapeutics, Inc. Executive Change in Control and Severance Plan and Summary Plan Description 1
12/34/56
EX-10
from 10-Q 6 pages Tenaya Therapeutics, Inc. Outside Director Compensation Policy (As Most Recently Amended and Restated March 16, 2023 (The “Restatement Date”))
12/34/56
EX-10
from 10-K 6 pages Tenaya Therapeutics, Inc. Outside Director Compensation Policy (As Most Recently Amended and Restated December 5, 2022 (The “Restatement Date”))
12/34/56
EX-10.2
from 10-K 49 pages Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan 1. Purposes of the Plan. the Purposes of This Plan Are: • to Attract and Retain the Best Available Personnel for Positions of Substantial Responsibility, • to Provide Additional Incentive to Employees, Directors and Consultants, and • to Promote the Success of the Company’s Business. the Plan Permits the Grant of Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units and Performance Awards. 2. Definitions. as Used Herein, the Following Definitions Will Apply: 2.1 “Administrator” Means the Board or Any of Its Committees as Will Be Administering the Plan, in Accordance With Section 4 of the Plan. 2.2
12/34/56
EX-10.14
from S-1/A 4 pages Tenaya Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.4
from S-1/A 25 pages Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 35 pages Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.13
from S-1 7 pages Tenaya Therapeutics, Inc. Executive Incentive Compensation Plan
12/34/56
EX-10.12
from S-1 17 pages Tenaya Therapeutics, Inc. Executive Change in Control and Severance Plan and Summary Plan Description
12/34/56
EX-10.11
from S-1 42 pages Industrial Lease – Multi-Tenant by and Between Terreno Park Union City LLC “Landlord” and Tenaya Therapeutics, Inc. “Tenant” Dated: February 12, 2021 Terreno Realty Corporation Industrial Lease
12/34/56
EX-10.10
from S-1 134 pages The Cove at Oyster Point Lease
12/34/56